In yet another in a series of evolving statements and backtracks, an official with the country's major pharmaceutical lobby said on Monday that it never struck a "quote, unquote secret deal with the White House" that would have prohibited the government from negotiating lower drug prices for Medicare.

"It was never brought up at the meeting," said Ken Johnson the senior vice president for the Pharmaceutical Research and Manufacturers of America, just days after his boss told the New York Times that the White House's commitment to not support price controls was, as far as he was concerned, "a done deal."...

We want to hear what you think about this article. Submit a letter to the editor or write to letters@theatlantic.com.